Erik Norström

Executive Vice President
Head of Corporate Development

1973, Swedish and Swiss citizen
Member since joining Tecan in 2017

Acquisitions remain an important contributor to our overall growth and a key element of our corporate strategy.

Erik Norström, Executive Vice President, Head of Corporate Development

Erik joined Tecan in December 2017 as Head of Corporate Development and a member of the Management Board.

Before that, he held a number of Corporate Development and M&A positions with increasing management responsibility in the broader healthcare and medical technology industries. From 2015-2017, Erik served as Corporate Vice President, Business Development and a member of the Corporate Leadership Team at Chr. Hansen Holding A/S, Denmark. From 2012 to 2015, Erik Norström was Head of Business Development and M&A at Nobel Biocare AG, Zürich, where he was responsible for the full range of business development and M&A activities, including corporate strategy. Prior to this, he was Head of M&A and Alliances at Nobel Biocare AG, Zürich (2008-2012), and from 2001-2008, he served as Corporate Development Director at F. Hoffmann-La Roche AG, Basel.

Erik holds a Master degree in Chemical Engineering (Chalmers University of Technology, Göteborg, Sweden) and a Bachelor degree in Business Administration with a specialization in Financial Management (Göteborg University of Economics, Sweden).

Professional background (most recent positions)

2015 - 2017

Corporate Vice President strategic development and M&A Member of the Corporate Leadership team at chr. Hansen a/s, Copenhagen, Denmark.

2012 - 2015

Head of Corporate Development and M&A

Member of the Corporate Leadership Team at Nobel Biocare AG, Zürich

2008 - 2012

Head of M&A and alliances at Nobel Biocare AG, Zürich

2001 - 2008

Corporate Development Director at F. Hoffmann-La Roche AG, Basel

1999 - 2001

Capex Analyst at F. Hoffmann-La Roche AG, Basel